Results 241 to 250 of about 104,967 (312)

Inhalable Exosomes in Respiratory Therapies with the Transformative Potential. [PDF]

Int J Nanomedicine
Gou J, Zhang L, Wang G, Li Z, Yin Q, Pan Y.   +5 more
europepmc   +1 more source

Effect of hydrogen inhalation on cardiovascular and interstitial components of pulmonary hypertension in rats

Т. А. Куропаткина, Khaydar Gufranov, F. Yu. Sychev, M. M. Artemieva, G. N. Bondarenko, Dmitry I. Esaulenko, Tatiana V. Samoylenko, V. V. Shyshkina, Medvedeva Na, Medvedev Os   +9 more
openalex   +2 more sources

The Therapeutic Potential of Farm Dust Extracts in a Mouse Model of Eosinophilic Inflammation

Allergy, EarlyView.
Farm dust extract (FDE) treatment reduces airway eosinophilia, mucus overproduction, and MHC‐II expression on DCs, limiting antigen presentation and Th2 inflammation. It increases PD‐L1 on DCs, promoting T cell deactivation. Additionally, FDE enhances Tregs and upregulates CTLA‐4, reinforcing suppression.
Rabia Ülkü Korkmaz, Jimmy Omony, Xiaomei Tan, Markus Klotz, Guilherme Dragunas, Sirui Chen, Soni Shankhwar, Zeynep Ertüz, Christoph Müller, Mohab Ragab, Aicha Jeridi, Romina Augustin, Janna Nawroth, Theodore S. Kapellos, Bettina Rankl, Ali Önder Yildirim, Erika von Mutius   +16 more
wiley   +1 more source

Vitamin D3-Deficient Diet Promotes Pulmonary Fibrosis Development in Murine Model of Hypersensitivity Pneumonitis. [PDF]

Int J Mol Sci
Lemieszek MK, Chojnacki M, Paśnik I, Gawryś W, Wilczyńska A, Leśniowska I, Anisiewicz J, Kiełbus M.   +7 more
europepmc   +1 more source

Decarbonising Respiratory Care: The Impact of a Low‐Carbon Salbutamol Pressurised Metered‐Dose Inhalers

Allergy, EarlyView.
Healthcare systems contribute up to 5% of global GHG emissions, with inhalers contributing a proportion of these. The carbon footprint of current salbutamol inhalers (pMDI with HFA‐134a propellant and DPI) and a planned salbutamol pMDI with low‐GWP propellant HFA‐152a was quantified across seven countries.
James King, Ashley Woodcock, Antonio Anzueto, Alexander J. K. Wilkinson, Christer Janson, Richard Henderson, Sourabh Fulmali, Maximilian Plank   +7 more
wiley   +1 more source

Toxic Effects of Sulfur Dioxide: A Review. [PDF]

Toxics
Stauffer CB, Tat J.
europepmc   +1 more source

“Super‐Responders” to Dupilumab Treatment in Patients With Primary Diffuse Chronic Rhinosinusitis With Nasal Polyps

Allergy, EarlyView.
This study aimed to evaluate the feasibility of extending dupilumab dosing intervals in T2‐CRSwNP by assessing how many patients maintain disease control with once‐every‐12‐weeks (Q12W) dosing and comparing clinical characteristics of super‐responders and excellent responders. Tapering of dupilumab to Q12W appears feasible in super‐responding patients.
P. E. Vonk, J. J. Otten, H. B. E. Elzinga, R. J. L. van der Lans, G. F. J. P. Adriaensen, L. B. L. Benoist, D. R. Hoven, W. J. Fokkens, S. Reitsma, PolyREG Consortium, A.B. Rinia, I. Krebbers, I.J. Kleiss, M. E. Cornet   +13 more
wiley   +1 more source

Inhalable nanoparticle-based drug delivery system for non-small cell lung cancer therapy: promises and challenges. [PDF]

Saudi Pharm J
Sakkal M, Abdelmoteleb RWA, Al Ali A, Jardan YAB, Löbenberg R, Sarfraz M.   +5 more
europepmc   +1 more source

Climate Change, Air Quality, and Pollen Allergies—State of the Art and Recommendations for Research and Public Health

Allergy, EarlyView.
ABSTRACT Allergies are one of the major health challenges of our time, associated with a high individual burden of disease and high costs for the healthcare system. Given their prevalence, allergies are also highly relevant from a public health perspective. The development of allergic diseases is multifactorial. In addition to individual factors (e.g.,
Jobst Augustin, Stefan Gilge, Heike Appel, Ute Dauert, Christina Endler, Ruth Heesen, Conny Höflich, Wilhelm Kuttler, Katharina Heinke Schlünzen, Wolfgang Straff, Barbora Werchan, Matthias Werchan, Torsten Zuberbier, Claudia Traidl‐Hoffmann   +13 more
wiley   +1 more source

Nebulized inhalation of novel baicalein liposome based on phospholipid complex to alleviate acute lung injury. [PDF]

Drug Deliv
Wen Z, Yu J, Meng Y, Du S, Shi Y, Jiang Y, Ye J, Liu Y, Xia X.   +8 more
europepmc   +1 more source